SCHEMBL5508637

SCHEMBL5508637

Nc1c(-c2ccccn2)c[nH]c1C(=O)O

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PIN1 Q13526 1/20 0.43
KDM4E B2RXH2 5/20 0.43
KDM6B O15054 1/20 0.43
KDM4A O75164 1/20 0.43
KDM5C P41229 1/20 0.43
KDM4C Q9H3R0 1/20 0.43
KDM2A Q9Y2K7 1/20 0.43
KDM3A Q9Y4C1 1/20 0.43
LMNA P02545 2/20 0.40
P4HTM Q9NXG6 2/20 0.40
L3MBTL1 Q9Y468 2/20 0.40
TDO2 P48775 1/20 0.40
NAPRT Q6XQN6 1/20 0.40
CYP1A2 P05177 1/20 0.38
POLB P06746 1/20 0.38
CCR1 P32246 1/20 0.38
CCR5 P51681 1/20 0.38
CCR8 P51685 1/20 0.38
METAP1 P53582 1/20 0.38
BLM P54132 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1477084 0.76 PRKCI (0.47) PIN1KDM4EKDM6BKDM4AKDM5C
SCHEMBL10819139 0.72 NAPRT (0.50) PIN1KDM4EKDM6BKDM4AKDM5C
SCHEMBL29852117 0.72 TGFBR1 (0.54) PIN1KDM4EKDM6BKDM4AKDM5C
SCHEMBL23294714 0.72 TGFBR1 (0.54) PIN1KDM4EKDM6BKDM4AKDM5C
SCHEMBL949058 0.69 PIN1 (0.49) PIN1KDM4EKDM6BKDM4AKDM5C
SCHEMBL26119478 0.69 PRKCI (0.46) PIN1KDM4EKDM6BKDM4AKDM5C
SCHEMBL8679235 0.69 KDM4E (0.42) KDM4ELMNAP4HTML3MBTL1TDO2
Dipyridyl SCHEMBL20448088 0.68 KDM4E (0.67) PIN1KDM4EKDM6BKDM4AKDM5C
SCHEMBL1173966 0.68 KDM4E (0.52) PIN1KDM4EKDM6BKDM4AKDM5C
SCHEMBL30457761 0.68 PRKCI (0.53) KDM4ELMNAP4HTML3MBTL1TDO2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1753724-A1 HETEROCYCLIC DERIVATIVES FOR TREATMENT OF HYPERLIPIDEMIA AND RELATED DISEASES AVANIR PHARMACEUTICALS (US) 2007-02-21 EP disclosed
WO-2005123686-A1 HETEROCYCLIC DERIVATIVES FOR TREATMENT OF HYPERLIPIDEMIA AND RELATED DISEASES AVANIR PHARMACEUTICALS (US) 2005-12-29 WO disclosed